These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34513662)

  • 1. Prognostic Score for
    Ji L; Fan L; Zhu X; Gao Y; Wang Z
    Front Oncol; 2021; 11():651636. PubMed ID: 34513662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With
    Wang Z; Wang H; Sun X; Fang Y; Lu SS; Ding SN; Chen XS; Shen KW
    Front Oncol; 2020; 10():14. PubMed ID: 32038988
    [No Abstract]   [Full Text] [Related]  

  • 3. An effective tool for predicting survival in breast cancer patients with
    Wang W; Liu J; Chen Y; Xu X; Huo L; Wang X; Gu J
    Front Surg; 2022; 9():939132. PubMed ID: 36684376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prognostic Model for Breast Cancer With Liver Metastasis.
    Ji L; Fan L; Zhu X; Gao Y; Wang Z
    Front Oncol; 2020; 10():1342. PubMed ID: 33014776
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
    Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study.
    Xiong Y; Shi X; Hu Q; Wu X; Long E; Bian Y
    Front Oncol; 2021; 11():600768. PubMed ID: 34150607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic nomogram for women with primary ovarian signet-ring cell carcinoma.
    Wang X; Ke X; Min J
    Ann Transl Med; 2021 Apr; 9(7):525. PubMed ID: 33987223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram Predicts the Role of Primary Tumor Surgery on
    Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
    Front Oncol; 2022; 12():819531. PubMed ID: 35600374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
    Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
    Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
    Lin H; Wu Y; Liang G; Chen L
    PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Risk Stratification Model to Predict Overall Survival and Surgical Benefit in Clear Cell Renal Cell Carcinoma With Distant Metastasis.
    Chen J; Cao N; Li S; Wang Y
    Front Oncol; 2021; 11():630842. PubMed ID: 33777784
    [No Abstract]   [Full Text] [Related]  

  • 15. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
    Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
    Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy.
    Li WZ; Hua X; Xie DH; Liang H; Liu GY; Xia WX; Xiang YQ
    ESMO Open; 2021 Feb; 6(1):100004. PubMed ID: 33399071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Nomogram Model to Identify Candidates and Predict the Possibility of Benefit From Primary Tumor Resection Among Female Patients With Metastatic Infiltrating Duct Carcinoma of the Breast: A Large Cohort Study.
    Wang Z; Chen B; Chen J; Wu Z; Gu H; Wang Y; Dai X
    Front Oncol; 2022; 12():798016. PubMed ID: 35237513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis.
    Zou Y; Yang Q; Wu Y; Ai H; Yao Z; Zhang C; Luo F
    Front Oncol; 2022; 12():840962. PubMed ID: 35372053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis.
    Chen J; Wu L; Zhang Z; Zheng S; Lin Y; Ding N; Sun J; Shi L; Xue M
    Cancer Med; 2021 Feb; 10(3):944-955. PubMed ID: 33350173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deep-learning-based clinical risk stratification for overall survival in adolescent and young adult women with breast cancer.
    Luo J; Diao B; Wang J; Yin K; Guo S; Hong C; Guo Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10423-10433. PubMed ID: 37277578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.